KLKim-Anne Lê

Kim-Anne Lê

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kim-Anne Lê has a total of 1 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Consommation de fructose: facteur déclenchant du syndrome métabolique ?

    by K. -A. Lê

    Le fructose est un sucre simple, dont la consommation a augmenté durant les dernières décennies, principalement par le biais d’une hausse de consommation de boissons sucrées. Chez le rongeur comme chez l’humain, un régime riche en fructose provoque expérimentalement de nombreuses altérations métaboliques, telles qu’une dyslipidémie, une résistance hépatique et musculaire à l’insuline et une déposition de lipides ectopiques. Ces effets mettent en avant le rôle délétère que pourrait avoir une alimentation riche en fructose dans la vie courante.


  • Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease

    by Kim-Anne Lê, Murielle Bortolotti

    The prevalence of nonalcoholic fatty liver disease is increasing worldwide and there is strong evidence that dietary factors play a role in its pathogenesis. The present review aims to provide a better understanding of how carbohydrates and other macronutrients may affect the disease. The effects of carbohydrates on the development of nonalcoholic fatty liver disease differ depending upon the carbohydrate type; high-glycemic index foods are related to increased hepatic fat in both rodents and humans. Similarly, simple carbohydrates, such as fructose, stimulate hepatic de-novo lipogenesis and decrease lipid oxidation, thus leading to increased fat deposition. The underlying mechanisms may involve the activation of transcription factors. Fat intake broadly leads to hepatic fat deposition in rodents but few data are available on humans. Both carbohydrates and fat trigger inflammatory factors, which are closely related to metabolic disorders and nonalcoholic fatty liver disease. Lifestyle interventions appear to be the most appropriate first-line treatment for nonalcoholic fatty liver disease. There is strong evidence that the diet may affect the development of nonalcoholic fatty liver disease. Although simple carbohydrates are clearly shown to have deleterious effects in humans, the role of fat remains controversial. Further studies will be required to evaluate the effects of macronutrient composition on the development of nonalcoholic fatty liver disease.